English | 简体中文 | 繁體中文 | 한국어
 All Press Releases
 
PharmaEngine will join Nanobiotix' pivotal trial for NBTXR3 in Soft Tissue Sarcoma to accelerate its development in Asia-Pacific
Oct 08, 2014 14:50 HKT
M+W 그룹, 머크社의 중국 제약공장 신축공사 수주
Oct 07, 2014 08:00 HKT
M+W集團簽訂與Merck公司中國最新製藥廠相關的重大合同
Oct 07, 2014 08:00 HKT
M+W集团签订与Merck公司中国最新制药厂相关的重大合同
Oct 07, 2014 08:00 HKT
The Effects of Growing Rice in Low Water and High Salt Conditions
Oct 03, 2014 12:35 HKT
INC - International Nut & Dried Fruit Council: Daily consumption of nuts may reduce the risk of cardiovascular diseases by 30%
Sep 30, 2014 07:00 HKT
에스페리테, 중간엽 줄기세포로 뇌성마비 치료제 개발 계획
Sep 27, 2014 15:00 HKT
Esperite社R&D部門「セルファクトリー」がGMP準拠の幹細胞生物生産技術を導入、第1弾は脳性麻痺の臨床試験を目標
Sep 27, 2014 09:30 HKT
Esperite 的研發部“細胞工廠”實施 GMP 幹細胞生物生產技術並將腦性麻痺作為首批臨床試驗目標
Sep 27, 2014 09:00 HKT
Esperite 的研发部“细胞工厂”实施 GMP 干细胞生物生产技术并将脑性麻痹作为首批临床试验目标
Sep 27, 2014 09:00 HKT
Protecting the Body from Itself
Sep 26, 2014 00:00 HKT
Esperite's R&D Division "The Cell Factory" implements GMP Stem Cell Bioproduction Technology and aims the Cerebral Palsy as first clinical trial
Sep 25, 2014 14:00 HKT
Monitoring Heavy Metals Using Mussels
Sep 19, 2014 12:20 HKT
Zebrafish Genes Linked to Human Respiratory Diseases
Sep 15, 2014 15:00 HKT
Ozone nano-bubble water: a potential treatment for severe gum infections
Sep 12, 2014 10:20 HKT
Introducing "Innovation for Inclusive Development" (IID) Fellows for Southeast Asia
Sep 03, 2014 15:20 HKT
Singaporean Birth Cohort Study Finds Benefits for Babies Exposed to Two Languages
Sep 02, 2014 12:00 HKT
Protein glue shows potential for use with biomaterials
Sep 01, 2014 18:00 HKT
Understanding and Improving the Body's Fight Against Pathogens
Sep 01, 2014 12:00 HKT
Novel Gene Predicts Both Breast Cancer Relapse and Response to Chemotherapy
Aug 20, 2014 12:00 HKT
<< Previous  Next >>
Copyright © 2024 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Privacy Policy | Terms of Use | RSS
US: +1 214 890 4418 | Beijing: +86 400 879 3881 | Hong Kong: +852 8192 4922 | Singapore: +65 6549 7068 | Tokyo: +81 3 6859 8575

Connect With us: